Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol in elderly patients undergoing ERCP
ChiCTR2400089307Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Dalian Medical University
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in biliary disease (3 arms), sponsored by The Second Affiliated Hospital of Dalian Medical University. Primary endpoints: Intraoperative blood pressure and Intraoperative heart rate. Started Sep 2024; status: recruiting.
02
Drugs
remimazolam
03
Conditions
biliary disease
Beyond the preview
Go deeper on ChiCTR2400089307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089307.